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ABSTRACT  
 
OBJECTIVE – To compare the effects of six weeks of high intensity interval training 
(HIT) to moderate intensity continuous training (MICT) on markers of cardio-
metabolic health, and glucose variability in people with type 1 diabetes. 
RESEARCH DESIGN AND METHODS – Fourteen previously sedentary people with 
type 1 diabetes (n=7 per group) completed six weeks of HIT or MICT three times per 
week and the effect on glucose variability using continuous glucose monitors (CGMS) 
and markers of cardio-metabolic health (aerobic capacity, blood lipid profile and 
arterial stiffness) were measured. Capillary blood glucose values were also recorded 
pre and post exercise to assess change in blood glucose concentration during 
exercise in the fed state.  
RESULTS – Six weeks of HIT or MICT improved ሶܸ O2peak by 14% and 15%, 
respectively (P<0.001), and aortic pulse wave velocity by 12% (P<0.001), with no 
difference between groups. CGMS data revealed no differences in incidence or 
percentage of time spent in hypoglycaemia following training in either group (P>0.05). 
The mean change in blood glucose concentration in response to HIT was -0.2 ± 0.5 
mmol/L, whereas blood glucose decreased by -5.5 ± 0.4 mmol/L in response to 
MICT in the fed state. 
CONCLUSIONS - Six weeks of HIT improved cardio-metabolic health markers to a 
similar degree as MICT. However, the finding that blood glucose remains stable 
during HIT in the fed state but consistently falls with MICT suggests that HIT may be 
a more practical option for patients with type 1 diabetes. 
 
ABREVIATIONS 
HIT – High intensity interval training 
MICT – Moderate intensity continuous training 
CON – Control day of no exercise 
aPWV – Aortic pulse wave velocity 
CGMS – Continuous glucose monitor system 
CHO - Carbohydrate 
SBP – Systolic blood pressure 
DBP – Diastolic blood pressure 
MAP – Mean arterial pressure 
EXTOD – Exercising for type 1 diabetes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
Regular exercise is recommended for people with type 1 diabetes to maintain overall 
health and reduce the risk of macrovascular and microvascular complications, which 
are a major cause of mortality and morbidity (1-3). The current guidelines for people 
with type 1 diabetes are to undertake at least 150 minutes of moderate to vigorous 
aerobic exercise per week, spread over at least three days per week, with no more 
than two consecutive days without activity (4). Benefits of exercise for those with 
type 1 diabetes include improved aerobic capacity ( ሶܸ O2max), insulin sensitivity, body 
composition, endothelial function and blood lipid profile (1; 5-7). Despite the benefits, 
few people with type 1 diabetes achieve exercise targets and many programmes 
designed to increase physical activity have failed (8; 9). In addition to the barriers to 
exercise cited by the general population, such as a perceived lack of time, work 
commitments and cost (10-12), people with type 1 diabetes face additional barriers 
including fear of hypoglycaemia, loss of glycaemic control and inadequate 
knowledge around exercise management (10; 12).  
 To overcome a perceived lack of time, high intensity interval training (HIT) is 
purported as a time-efficient alternative to moderate-intensity exercise to improve 
numerous cardio-metabolic risk factors including ሶܸ O2max, insulin sensitivity and 
glycaemic control in people without  type 1 diabetes (13; 14). However these benefits 
have not been explored in people with type 1 diabetes. Recent results from our 
laboratory (Scott et al. companion paper) show that HIT can be undertaken in the 
fasted state safely and without hypoglycaemia. However this has not been explored 
in the fed state. 
Here we investigated the hypothesis that six weeks of HIT would improve 
markers of cardio-metabolic health, including ሶܸ O2peak, glycaemic control and vascular 
health, in people with type 1 diabetes. A moderate intensity continuous training 
(MICT) group was used as a control. During this 6-week training period blood 
glucose concentrations were monitored before and after all exercise sessions to 
explore the acute effects of HIT and MICT on blood glucose concentration.  
 
RESEARCH DESIGN AND METHODS 
Fourteen previously sedentary people with type 1 diabetes (10 men/4 women; see 
Table 1 for subject characteristics) on a basal-bolus insulin regimen completed six 
weeks of supervised HIT (n = 7) or MICT (n = 7) three times per week. Participants 
were pair-matched based on sex, age and ሶܸ O2peak to the two training groups. 
Exclusion criteria were duration of type 1 diabetes <6 months, insulin pump therapy, 
significant history of hyper or hypoglycaemia, obesity (BMI >32 kg·m-2), pregnancy or 
planning pregnancy, uncontrolled hypertension (>180/100 mmHg), angina, 
autonomic neuropathy, taking any medication that affects heart rate, major surgery 
planned within 6 weeks of the study, severe nonproliferative and unstable 
proliferative retinopathy. Testing took place in the laboratory of the School of Sport 
and Exercise Sciences at Liverpool John Moores University. The study was 
approved by the Black Country NHS Research Ethics Committee (West Midlands, 
UK) and all participants gave written informed consent to a protocol conforming to 
the Declaration of Helsinki.  
 
 
Pre-training assessments 
Participants first performed an incremental exercise test to exhaustion on an 
electromagnetically braked cycle ergometer (Excalibur Sport V2.0, Lode, Groningen, 
The Netherlands) to determine maximal aerobic power output (Wmax) and ሶܸ O2peak 
using an online gas collection system (MOXUS modular oxygen uptake system, AEI 
technologies, Pittsburgh, PA). The test consisted of 3-minute stages starting at 60 W, 
and the workload was increased by 35 W at each stage until subjects could not 
maintain a cadence of >50 rpm, at which point the test was terminated. ሶܸ O2peak was 
taken as the highest value achieved over a 15 second recording period.  Participants 
also completed a food diary over a minimum of three days in order to calculate 
habitual caloric and macronutrient intake. 
Three to 7 days after the incremental exercise test, participants attended the 
laboratory after an overnight fast (>10 h) for a second pre-training assessment 
session. Following 15 minutes rest, supine brachial artery blood pressure 
measurements were made in triplicate using an automated sphygmomanometer (GE 
DINAMAP Pro 300 V2). Aortic pulse wave velocity (aPWV) measurements were 
made using a semi-automated device and software (SphygmoCor, AtCor Medical, 
Sydney, Australia), as previously described Cocks et al. (15). A fasting blood sample 
was used to determine fasting plasma cholesterol and triglyceride concentrations, 
using a semi-automatic spectrophotometer (Randox RX Series, the RX Daytona™).  
A Dexcom G4 Platinum (Dexcom, San Diego, CA, USA) CGMS was inserted 
subcutaneously on the abdomen. A habitual free-living 24-hour glucose profile was 
at least 24 hours after the CGMS was inserted. Participants were trained to use the 
CGMS and instructed to calibrate the device a minimum of four times daily using 
capillary blood tests. Participants were provided with a standardised diet of three 
meals (breakfast, lunch and dinner) during the CGMS period (50% CHO; 30% fat; 20% 
protein) in accordance with their habitual calorie intake. No additional snacks were 
permitted and participants only consumed the food provided by the research team 
during this period, unless they needed to prevent hypoglycaemia. Participants were 
instructed to consume these meals at pre-determined time points throughout the day 
and no additional snacks were permitted other than to prevent hypoglycaemia. A 
food diary was completed to confirm that they had consumed the prescribed food at 
the correct times. Participants were instructed to avoid alcohol and caffeine, as well 
as exercise throughout the CGMS period.  
 
Exercise Training  
Training started ~72h after completion of the pre-experimental procedures. 
Participants trained three times per week for six weeks under researcher supervision 
on a Lode Corival cycle ergometer (Corival Lode BV, Groningen, The Netherlands). 
Following a 3 minute low-intensity warm-up, the HIT group performed repeated 1 
minute bouts of high intensity cycling at a workload equivalent to 100% ሶܸ O2peak 
interspersed with 1 minute of recovery at 50 W, whereas the MICT group performed 
continuous moderate intensity cycling at a workload equivalent to 65% ሶܸ O2peak. The 
number of intervals in the HIT group increased from 6 in weeks 1 and 2, to 8 in 
weeks 3 and 4 to 10 in weeks 5 and 6. The duration of the sessions in the MICT 
group were 30 minutes in weeks 1 and 2, 40 minutes in weeks 3 and 4 and 50 
minutes in weeks 5 and 6. 
 
Acute change in blood glucose with exercise 
Before starting and after completing each training session during the 6 week training 
period, participant’s blood glucose concentrations were required to be between 7-14 
mmol/L, in accordance with the Exercising for Type 1 Diabetes (EXTOD) guidelines 
(16).  If blood glucose concentrations fell outside of this range corrective measures 
were taken; glucose was ingested if blood glucose <7 mmol/L, and a light walk or 
insulin was advised if glucose >14 mmol/L, as well as checking blood ketones (17). 
During the MICT sessions participants were advised to check their blood glucose 
concentrations part-way through the exercise and to consume carbohydrate as 
necessary to prevent hypoglycaemia. Capillary blood glucose concentrations were 
recorded before and after exercise and whether the exercise session was 
undertaken in the fasted (>10 hours) or fed state (last meal consumed <4h previous). 
As such, over the course of the six weeks of training we gathered pre and post 
exercise blood glucose concentrations from a total of 108 MICT training sessions 
and 87 HIT sessions in the fed state. The proportion of total sessions that blood 
glucose was recorded was 86%. 
 
Post-training assessments 
Approximately 72h after the final training session, participants attended the 
laboratory on two occasions (separated by 72h) to complete a series of post-training 
assessments.  These assessments were identical in all respects to those undertaken 
prior to training (pre-training assessments).   
 
Statistical analyses 
The primary outcome variable was ሶܸ O2peak. Previous research in our group (18; 19) 
has suggested a SD of 2.7-3.2 to detect a change in ሶܸ O2peak of 3.5 ml∙kg∙min‐1, which 
is a clinically significant increase in ሶܸ O2peak (20). A power calculation suggested that 
7-9 participants were required in each group to detect a within-group difference with 
a paired t test with 80% power at a significance level of 0.05. Continuous glucose 
monitor data were downloaded from the device using Dexcom Studioᵀᴹ software 
(12.0.4.6) and analysed in accordance with the International Consensus on Use of 
Continuous Glucose Monitoring (21). Glycaemic thresholds were defined as follows: 
target range (3.9-10 mmol/L), level 1 hypoglycaemia (≤3.9 mmol/L), level 2 
hypoglycaemia (≤2.9 mmol/L) and hyperglycaemia (≥10 mmol/L). The 24-hour period 
was defined as 08:00-08:00h and the nocturnal period was defined as 24:00-06:00h. 
All variables were analysed using a two-way mixed ANOVA, with the between factor 
‘group’ (HIT vs. MICT) and repeated factor ‘training status’ (pre-training vs. post 
training), followed by Bonferroni post-hoc corrections. A two way mixed ANOVA, with 
the between factor ‘group’ and the repeated factor ‘time point’ (pre-training vs. post 
training) was used to assess whether there was an acute change in blood glucose 
concentration following HIT and MICT in the fed state over the 6 weeks of training. 
The CGMS did not work on one participant in the MICT group. Aortic PWV readings 
were obtained from five participants in the HIT group and six in the MICT group. All 
analyses were performed using IBM SPSS Statistics for Windows, Version 22.0. 
Armonk, NY: IBM Corp. Data are presented as mean ± SEM and significance was 
set at P≤0.05. 
 
RESULTS 
By design, there were no differences in age (P=0.877), ሶܸ O2peak (P=0.371) or duration 
of type 1 diabetes (P=0.291) between the training groups at baseline. BMI was, 
however, significantly higher in the HIT group compared to the MICT group 
(P=0.038). Pre and post training variables are presented in Table 1. Training 
increased ሶܸ O2peak (HIT 14%, MICT 15%; P<0.001) and Wmax (HIT 13%, MICT 14%; 
P<0.001), with no difference between groups (Fig. 1). Six weeks of training also 
improved aPWV (P=0.001) and there was no difference between groups. Systolic, 
diastolic and mean arterial blood pressure did not improve following training 
(P=0.219; P=0.476; P=0.268, respectively). There was also no change in plasma 
cholesterol or triglyceride concentrations with training (P=0.881; P=0.652). 
 
Glycaemic control 
Glucose data from the CGMS obtained over a 24-hour period pre and post training 
are presented in Table 2. There was no difference in the time spent in level 1 
hypoglycaemia (≤3.9 mmol/L) over the 24-hour period (P=0.727) or nocturnal period 
(P=289) with training. Similarly, there was no difference in time spent in level 2 
hypoglycaemia (≤2.9 mmol/L) with training over the 24-hour period (P=0.442) or 
nocturnal period (P=0.397). There were also no differences in the time spent in 
target range over the 24-hour (P=0.412) or nocturnal periods (P>0.382). Furthermore, 
there was no difference in the time spent in hyperglycaemia over the 24-hour 
(P=0.540) or nocturnal period (P=0.118). However, there was an interaction effect for 
the time spent in target range (P=0.034) and time in hyperglycaemia over the 
nocturnal period (P=0.039). Post hoc analysis revealed that the HIT group spent 
significantly less time in target glycaemia during the nocturnal period (P=0.038) 
which was due to a greater time spent in hyperglycaemia over the nocturnal period 
(P=0.016). The incidence of level 1 hypoglycaemia over the 24-hour period (P=0.675) 
and nocturnal period (P=0.363) was no different with training. There were no 
differences in the incidence of level 2 hypoglycaemia over the 24-hour (P=0.174) or 
nocturnal (P=0.549) with training.  
 
Acute change in blood glucose during training 
When quantifying the change in blood glucose concentration during exercise training 
sessions undertaken in the fed state over the six week intervention, the mean 
change in blood glucose concentration in response to HIT was -0.2 ± 0.5 mmol/L 
whereas blood glucose decreased by -5.5 ± 0.4 mmol/L in response to MICT (Fig. 2).  
 
CONCLUSIONS 
This study demonstrates for the first time that six weeks of HIT improves ሶܸ O2peak and 
aPWV in people with type 1 diabetes to a similar magnitude as MICT. Secondly, we 
observed that blood glucose concentration remained stable during HIT when 
participants exercised in the fed state throughout the training programme, but there 
was a consistently large drop in blood glucose during MICT, with patients at risk of 
hypoglycaemia. The CGMS data revealed no difference between HIT and MICT 
other than during the nocturnal period where there was an increase in the time spent 
in hyperglycaemia. The fact that HIT is as effective as MICT but does not cause a fall 
in glucose during exercise means that it may be a more practical exercise for 
patients with type 1 diabetes. 
Aerobic capacity improved to a similar extent following six weeks of HIT and 
MICT, despite the weekly time commitment being 47-60% less for HIT than for MICT. 
The 14% increase in ሶܸ O2peak observed in our investigation following HIT (a mean 
increase of 4.9 ml·kg·min-1) is high in comparison to other studies using similar 
protocols that tend to report changes of 7-10% in populations without type 1 diabetes 
(22) and the only other study to examine the effect of sprint interval training in type 1 
diabetics (repeated 30-second maximal cycling bouts interspersed with 3-4 minutes 
of rest 3 times a week for 7 weeks) reported a 7% increase in ሶܸ O2peak (23). This has 
clinical importance given that ሶܸ O2max is reported to be the strongest prognostic 
marker of cardiovascular mortality (20) and improvements in	 ሶܸ O2max with exercise 
training are associated with a reduction in all-cause mortality risk (24). In fact, Myers 
(20) found that there is a 8-17% reduction in all-cause mortality for each 1-MET (~3.5 
ml·kg·min-1) increase in ሶܸ O2max. Although these correlations have not been 
specifically confirmed in people with type 1 diabetes, it is likely that the HIT 
programme used here induces clinically meaningful benefits to this population, which 
is especially important as they are at increased risk of cardiovascular disease 
compared to a non-diabetic population (1; 2).  
In the present study there was a 12% reduction in aPWV following both 
training modes, which is greater than has previously been reported in other training 
studies in populations without type 1 diabetes (25; 26). To the authors’ knowledge, 
this is the first study to investigate changes in arterial stiffness following HIT and 
MICT in people with type 1 diabetes. The reduction in aPWV is of clinical relevance 
as increased arterial stiffness is associated with negative cardiovascular outcomes 
(27).  
Neither training mode improved glycaemic control according to the CGMS 
data, measured as time spent in target range (euglycaemia) or hypoglycaemia or the 
incidences of hypoglycaemia. Previous studies using HbA1c and daily insulin dosage 
as a marker of glycaemic control have also failed to show overall improvements in 
glycaemic control with exercise training (23; 28; 29), although studies reporting 
positive effects of training on glycaemic control do exist (30). There was a reduction 
in the time spent in euglycaemia in the HIT group which was due to an increase in 
the time spent in hyperglycaemia. Although increasing the proportion of time spent in 
hyperglycaemia during the nocturnal period is not desirable, it at least reduces the 
risk of developing hypoglycaemia. It could be speculated that participants in the HIT 
group consumed additional carbohydrates before bed to prevent hypoglycaemia and 
as a result spent more time in hyperglycaemia. However, the study was performed 
under strict dietary control and participants in the HIT group did not report consuming 
additional snacks. The small sample size and the fact that just one 24 hour period 
was recorded is more likely to account for these differences. Although the use of 
CGMS in our investigation allowed a detailed analysis of glycaemic control, we 
acknowledge that longer duration exercise training programmes with larger sample 
sizes are needed to assess the effects of exercise training on long-term glycaemic 
control. Furthermore, the current guidelines suggest that a minimum of 14 
consecutive days should be recorded when analysing CGMS data (21). 
Unfortunately, these guidelines were published after our data collection was 
completed so will have to form the recommendations for our future work. 
Before the training sessions, we recorded blood glucose concentration for 
safety reasons to prevent participants from exercising when glucose concentrations 
were too high or low based on the EXTOD guidelines (16), and after the sessions so 
that they did not leave the laboratory while they were at increased risk of 
hypoglycaemia. This meant that we collected pre and post exercise blood glucose 
readings from up to 18 training sessions for each participant over the course of six 
weeks HIT or MICT. We found that blood glucose concentration remained stable 
during HIT when participants exercised in the fed state throughout the training 
programme, but there was a consistently large drop in blood glucose during MICT in 
the fed state, with patients at risk of hypoglycaemia. This was a consistent 
observation across all participants undertaking MICT (Fig. 2b). The changes in blood 
glucose concentration during the exercise we have reported here are striking and are 
the first of their kind in the literature over so many training sessions. Furthermore, 
they are supported by Garcia-Garcia et al. (31) who conducted a systematic review 
and meta-analysis in which they aggregated results from 10 studies to estimate rate 
of change of glucose concentration during and after different types of exercise in 
people with type 1 diabetes. Their results showed a rapid decline in glycaemia during 
continuous exercise (-4.43 mmol/L h-1 on average) while the results were more 
variable during intermittent high intensity exercise depending on the protocol.  
The instability in blood glucose that we observed during the MICT in the fed 
state is likely due to the effect of short-acting insulin in the circulation. During 
moderate intensity exercise in healthy individuals, blood glucose concentration 
remains stable because insulin secretion is suppressed at the onset of exercise and 
there is an increase in adrenaline and growth hormone, resulting in increased 
hepatic glucose production, lipolysis and reduced peripheral glucose uptake. 
However, because insulin is supplied exogenously in people with type 1 diabetes, 
they are unable to reduce circulating insulin which limits the effects of glucagon on 
hepatic glucose production, increases peripheral glucose uptake and delays lipolysis. 
The combination of insulin and exercise-mediated glucose disposal coupled with 
decreased hepatic glucose production increases the risk of hypoglycaemia. During 
HIT, insulin does not tend to decrease even in healthy individuals, presumably 
because the exercise bout is too short. Previous research has also shown there is a 
rise in catecholamines and blood lactate during high intensity exercise which may 
increase gluconeogenesis and could also be a contributing factor for the attenuated 
decline in glucose during exercise where high intensity bouts are added to a MICT 
session (32-34). The implications from these findings are important for people with 
type 1 diabetes that want to exercise as they show that HIT can be performed in the 
fed state without significant reduction in blood glucose concentration.  
Another important observation, although not quantitatively reported here, was 
the number of training sessions in which participants had to prevent or treat an 
episode of hypoglycaemia by consuming fast-acting carbohydrate. During the MICT 
sessions, participants were advised to stop exercising at least once to check their 
blood glucose concentration, correct accordingly with glucose if necessary, and then 
wait for their blood glucose to stabilise before recommencing the training. However, 
all participants were able to complete the HIT sessions without interruption. Many of 
the participants in the MICT condition found this frustrating and it would often mean 
that the already time consuming 50 minute cycling sessions were even longer while 
blood glucose was checked. The large drop in blood glucose concentration that we 
found during the MICT sessions highlights why the guidelines recommend that 
carbohydrate should be taken when doing more than 30 minutes of moderate 
intensity exercise (17).  
The main strengths of this investigation were 1) the strict dietary 
standardisation under free-living conditions during the CGMS period pre and post 
training, and 2) the monitoring of acute changes in blood glucose concentrations 
during exercise throughout the intervention. However, we acknowledge that there 
are some limitations. The sample size of the study was small; however, the clear 
increases in ሶܸ O2peak suggest that we have the power to conclude that HIT is effective 
at improving ሶܸ O2peak at least. Secondly, we did not record insulin dose before and 
after training. This would be useful to determine whether there is a change in insulin 
sensitivity as reduced insulin dosage is associated with decreased risk of 
cardiovascular complications in people with type 1 diabetes (35; 36). 
In summary, this is the first study to demonstrate that six weeks of HIT leads 
to comparable improvements in ሶܸ O2peak and arterial stiffness to MICT. HIT though 
may be the preferred approach, as blood glucose remains stable during HIT but falls 
during MICT. We therefore recommend that HIT is a safe, effective, flexible and time 
efficient form of exercise for people with type 1 diabetes. 
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Figure 2 - Change in blood glucose following exercise in the fed state 
Finger prick blood glucose concentrations were recorded before and after exercise 
and whether the exercise session was undertaken in the fasted (>10 hours) or fed 
state, as well as information about the timing of the last insulin dose. As such, over 
the course of the six weeks of training we gathered pre and post exercise blood 
glucose concentrations from a total of 108 MICT training sessions and 87 HIT 
sessions in the fed state (86% of total possible sessions). A shows mean change in 
blood glucose concentration and B shows individual changes during HIT and MICT. 
*denotes a significant change from baseline (P<0.05). 
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Table 1 - General characteristics 
 HIT MICT 
 Pre Post Pre Post 
Age (years) 29 ± 3 - 29 ± 5 - 
Sex 5M/2F - 5M/2F - 
Duration of T1D 
(years) 
13 ± 3 - 9 ± 2 - 
Mass (kg) 90.0 ± 4.8 89.8 ± 4.8 76.7 ± 5.4 76.3 ± 5.3 
BMI (kg·m-2) 29.2 ± 1.2 29.2 ± 1.2 25.3 ± 1.2 25.2 ± 1.2 
ሶܸ O2peak (ml·kg·min-1) 35.6 ± 2.6 40.5 ± 2.6* 32.1 ± 2.6 36.9 ± 3.2* 
ሶܸ O2peak (L/min-1) 3.2 ± 0.3 3.7 ± 0.3* 2.5 ± 0.3 2.9 ± 0.4* 
Wmax (W) 245 ± 16 277 ± 19* 202 ± 22 231 ± 24* 
SBP (mmHg) 121 ± 3 119 ± 4 123 ± 4 122 ± 4 
DBP (mmHg) 65 ± 3 63 ± 3 70 ± 5 68 ± 4 
MAP (mmHg) 84 ± 3 82 ± 2 87 ± 4 86 ± 3 
aPWV (m/s) 6.1 ± 0.5 5.4 ± 0.7* 6.1 ± 0.4 5.4 ± 0.4* 
Cholesterol (mmol/L) 5.07 ± 0.29 5.12 ± 0.35 4.81 ± 0.41 4.93 ± 0.41 
Triglycerides (mmol/L) 0.94 ± 0.09 1.03 ± 0.25 0.70 ± 0.04 0.65 ± 0.06 
 
BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood 
pressure; MAP = mean arterial pressure; aPWV = arterial pulse wave velocity. Data 
are presented as mean ± SEM. * denotes a significant change from pre-training to 
post-training (P<0.05). 
 
Table 2 - Summary of continuous glucose monitor data  
 HIT  MICT 
 Pre Post  Pre Post 
24-hr period      
Mean glucose (mmol/L) 9.3±0.3 9.5±1.0  9.2±0.6 8.6±0.7 
CV (%) 42.6±3.6 38.2±2.6  37.9±3.6 36.9±4.0 
Time in level 1 
hypoglycaemia (%) 
6.1±2.6 5.4±3.1  3.4±1.5 2.8±1.9 
Time in level 2 
hypoglycaemia (%) 
0.2±0.2 0.5±0.3  0.9±0.5 0.0±0.0 
Time in range (%) 56.7±3.1 56.4±7.8  59.3±5.8 68.2±7.7 
Time in hyperglycaemia  
(%) 
37.0±2.0 37.7±8.9  36.3±6.5 28.9±8.5 
Incidence of level 1 
hypoglycaemia 
1.8±0.6 1.2±0.5  0.9±0.5 1.4±0.6 
Incidence of level 2 
hypoglycaemia 
0.2±0.2 0.2±0.2  0.4±0.2 0.1±0.1 
Incidence of 
hyperglycaemia 
3.0±0.5 2.8±0.5  3.2±0.5 2.5±0.5 
Nocturnal period      
Mean glucose (mmol/L) 8.8±1.3 11.7±2.0  8.0±1.2 7.4±1.1 
CV (%) 23.2±5.9 19.5±9.1  29.1±7.2 22.2±6.2 
Time in level 1 
hypoglycaemia (%) 
9.3±9.0 3.0±2.0  7.6±5.0 4.9±4.9 
Time in level 2 
hypoglycaemia (%) 
0.0±0.0 1.2±1.2  3.2±2.0 0.0±0.0 
Time in range (%) 57.4±15.5 32.6±14.3*  60.0±15.4 71.3±16.5
Time in hyperglycaemia  
(%) 
33.3±16.7 63.0±16.3*  28.5±15.9 23.6±15.8
Incidence of level 1 
hypoglycaemia 
0.5±0.2 0.3±0.2  0.3±0.2 0.1±0.1 
Incidence of level 2 
hypoglycaemia 
0.0±0.0 0.2±0.2  0.3±0.2 0.0±0.0 
Incidence of 
hyperglycaemia 
0.5±0.2 0.8±0.2  0.5±0.2 0.3±0.2 
 
The 24-hour period was defined as 08:00-08:00h and nocturnal period as 24:00-
06:00h. Level 1 hypoglycaemia (≤3.9 mmol/L), level 2 (severe) hypoglycaemia (≤2.9 
mmol/L), target range (3.9-10 mmol/L) and hyperglycaemia (≥10 mmol/L). There 
were no differences in any of the variables with training (P>0.05). 
 
 
 
 
 
 
 
 
 
 
 
